UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interactions among the Escherichia coli mutT, mutM, and mutY damage prevention pathways

DNA repair, 2003-02, Vol.2 (2), p.159-173

2003

Volltextzugriff (PDF)

Genetic requirements and mutational specificity of the Escherichia coli SOS mutator activity

Journal of Bacteriology, 1997-12, Vol.179 (23), p.7435-7445

1997

Volltextzugriff (PDF)

Hypersensitivity of Escherichia coli Δ(uvrB-bio) Mutants to 6-Hydroxylaminopurine and Other Base Analogs Is Due to a Defect in Molybdenum Cofactor Biosynthesis

Journal of Bacteriology, 2000-06, Vol.182 (12), p.3361-3367

2000

Volltextzugriff (PDF)

Transcription-Repair Coupling Determines the Strandedness of Ultraviolet Mutagenesis in Escherichia coli

Proceedings of the National Academy of Sciences - PNAS, 1992-11, Vol.89 (22), p.11036-11040

1992

Volltextzugriff (PDF)

Spectra of Spontaneous Mutations in Escherichia coli Strains Defective in Mismatch Correction: The Nature of in vivo DNA Replication Errors

Proceedings of the National Academy of Sciences - PNAS, 1987-09, Vol.84 (17), p.6220-6224

1987

Volltextzugriff (PDF)

Mutants of Escherichia coli With Increased Fidelity of DNA Replication

Genetics (Austin), 1993-08, Vol.134 (4), p.1023-1030

1993

Volltextzugriff (PDF)

Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor

Journal of bacteriology, 2000-06, Vol.182 (12), p.3361

2000

Volltextzugriff (PDF)

Mechanisms of ultraviolet-induced mutation: Mutational spectra in the Escherichia coli lacI gene for a wild-type and an excision-repair-deficient strain

Journal of molecular biology, 1987-11, Vol.198 (2), p.187-202

1987

Volltextzugriff (PDF)

The C-C (6-4) UV Photoproduct is Mutagenic in Escherichia coli

Proceedings of the National Academy of Sciences - PNAS, 1986-09, Vol.83 (18), p.6945-6949

1986

Volltextzugriff (PDF)

Mechanisms of ultraviolet-induced mutation

Journal of molecular biology, 1987-11, Vol.198 (2), p.187-202

1987

Volltextzugriff (PDF)

The antimutator phenotype of E. coli mud is only apparent and results from delayed appearance of mutants: Molecular mechanisms of anticarcinogenesis and antimutagenesis

Mutation research, 2001, Vol.480-81, p.71-75

2001

Volltextzugriff (PDF)

The antimutator phenotype of E. coli mud is only apparent and results from delayed appearance of mutants

Mutation research, 2001-09, Vol.480, p.71-75

2001

Volltextzugriff (PDF)

Effect of Escherichia coli dnaE antimutator mutants on mutagenesis by the base analog N4-aminocytidine

Mutation research, 1998-06, Vol.402 (1), p.23-28

1998

Volltextzugriff (PDF)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

PloS one, 2014-03, Vol.9 (3), p.e90772

2014

Volltextzugriff (PDF)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

PloS one, 2012-04, Vol.7 (4), p.e33672

2012

Volltextzugriff (PDF)

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Antiviral therapy, 2012-01, Vol.17 (7), p.1363-1373

2012

Volltextzugriff (PDF)

Discovery of potent, soluble and orally active TRPV1 antagonists. Structure–activity relationships of a series of isoxazoles

Bioorganic & medicinal chemistry letters, 2011-08, Vol.21 (15), p.4652-4657

2011

Volltextzugriff (PDF)

HIV prevention trial design in an era of effective pre-exposure prophylaxis

HIV clinical trials, 2017-11, Vol.18 (5-6), p.177-188

2017

Volltextzugriff (PDF)

Marsh and forested wetland reclamation of a central Florida phosphate mine

Wetlands (Wilmington, N.C.), 1984-12, Vol.4 (1), p.87-104

1984

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Interactions among the Escherichia coli mutT, mutM, and mutY damage prevention pathways

Genetic requirements and mutational specificity of the Escherichia coli SOS mutator activity

Hypersensitivity of Escherichia coli Δ(uvrB-bio) Mutants to 6-Hydroxylaminopurine and Other Base Analogs Is Due to a Defect in Molybdenum Cofactor Biosynthesis

Transcription-Repair Coupling Determines the Strandedness of Ultraviolet Mutagenesis in Escherichia coli

Spectra of Spontaneous Mutations in Escherichia coli Strains Defective in Mismatch Correction: The Nature of in vivo DNA Replication Errors

Mutants of Escherichia coli With Increased Fidelity of DNA Replication

Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor

Mechanisms of ultraviolet-induced mutation: Mutational spectra in the Escherichia coli lacI gene for a wild-type and an excision-repair-deficient strain

The C-C (6-4) UV Photoproduct is Mutagenic in Escherichia coli

Mechanisms of ultraviolet-induced mutation

The antimutator phenotype of E. coli mud is only apparent and results from delayed appearance of mutants: Molecular mechanisms of anticarcinogenesis and antimutagenesis

The antimutator phenotype of E. coli mud is only apparent and results from delayed appearance of mutants

Effect of Escherichia coli dnaE antimutator mutants on mutagenesis by the base analog N4-aminocytidine

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Discovery of potent, soluble and orally active TRPV1 antagonists. Structure–activity relationships of a series of isoxazoles

HIV prevention trial design in an era of effective pre-exposure prophylaxis

Marsh and forested wetland reclamation of a central Florida phosphate mine

Suchergebnisse filtern